NASDAQ: FBIO
Fortress Biotech Inc Stock Ownership - Who owns Fortress Biotech?

Insider buying vs selling

Have Fortress Biotech Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
David JinChief Financial Officer2026-04-012,967$2.18
$6.46kBuy
David JinChief Financial Officer2025-10-012,711$1.31
$3.55kBuy

1 of 1

FBIO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when FBIO insiders and whales buy or sell their stock.

FBIO Shareholders

What type of owners hold Fortress Biotech Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Lindsay A. Md Rosenwald21.24%7,054,507$19.54MInsider
Michael S. Weiss6.85%2,276,562$6.31MInsider
Elliott Associates LP6.25%2,076,381$5.75MInsider
Elliott International LP4.98%1,654,898$4.58MInsider
David Jin3.77%1,251,571$3.47MInsider
Opaleye Management Inc3.14%1,042,000$2.89MInstitution
Vanguard Capital Management LLC2.91%966,030$2.68MInstitution
George Avgerinos1.97%655,170$1.81MInsider
Shikiar Asset Management Inc0.92%305,469$846.15kInstitution
Geode Capital Management LLC0.87%290,255$804.01kInstitution

1 of 3

FBIO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
FBIO16.09%48.60%Net BuyingNet Buying
RANI34.48%32.99%Net Selling
ATHE0.00%0.17%
SEER37.66%62.34%Net SellingNet Selling
CBUS28.69%64.69%Net BuyingNet Selling

Fortress Biotech Stock Ownership FAQ

Who owns Fortress Biotech?

Fortress Biotech (NASDAQ: FBIO) is owned by 16.09% institutional shareholders, 48.60% Fortress Biotech insiders, and 35.30% retail investors. Lindsay A. Md Rosenwald is the largest individual Fortress Biotech shareholder, owning 7.05M shares representing 21.24% of the company. Lindsay A. Md Rosenwald's Fortress Biotech shares are currently valued at $20.18M.

If you're new to stock investing, here's how to buy Fortress Biotech stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.